Your browser doesn't support javascript.
loading
Imaging adjuvants in pediatric surgical oncology.
Fusco, Joseph C; Abdelhafeez, Abdelhafeez H; Krauel, Lucas; Honeyman, Joshua N; Ehrlich, Peter F; Wijnen, Marc; Lautz, Timothy B; Pachl, Maximillian; Malek, Marcus M.
Afiliação
  • Fusco JC; Department of Pediatric Surgery, Monroe Carell Jr. Children's Hospital, Vanderbilt University, Nashville, Tennessee, USA.
  • Abdelhafeez AH; Department of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Krauel L; Department of Surgery, St. Joan de Deu Barcelona Children's Hospital, Barcelona, Spain.
  • Honeyman JN; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Ehrlich PF; Division of Pediatric Surgery, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan, USA.
  • Wijnen M; Department of Pediatric Surgery, Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.
  • Lautz TB; Department of Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, Illinois, USA.
  • Pachl M; Department of Surgery, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Malek MM; Division of Pediatric General and Thoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Pediatr Blood Cancer ; : e31241, 2024 Aug 05.
Article em En | MEDLINE | ID: mdl-39101518
ABSTRACT
Surgery is a crucial component of pediatric cancer treatment, but conventional methods may lack precision. Image-guided surgery, including fluorescent and radioguided techniques, offers promise for enhancing tumor localization and facilitating precise resection. Intraoperative molecular imaging utilizes agents like indocyanine green to direct surgeons to occult deposits of tumor and to delineate tumor margins. Next-generation agents target tumors directly to improve specificity. Radioguided surgery, employing tracers like metaiodobenzylguanidine (MIBG), complements fluorescent techniques by allowing for detection of tumors at a greater depth. Dual-labeled agents combining both modalities are under development. Three-dimensional modeling and virtual/augmented reality aid in preoperative planning and intraoperative guidance. The above techniques show great promise to benefit patients with pediatric tumors, and their continued development will almost certainly improve surgical outcomes.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos